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    Background – The aim of our study was the follow up of a patient presented only with dry 
chronic cough:Which is the main diagnostic procedure and the most effective therapeutic approach available for such patients at the 
first medical visit and during his follow up? 
Methods  -  Seventy patients (21 males and 49 females) age of 40, 47 year,presented only with chronic non productive cough were 
studied. They did accomplish 3 medical controls for a period of 8 months with a distance of 4 months from each other. A detailed 
history was taken to evaluate the existence of other contributing factors to chronic cough such as: Athma,GERD,PNDS, and any 
respiratory infections. Only 65.71% of them accepted to undergo the Methacholline challenge test and the measurement of Exhaled 
nitric oxid. 
Results – From 41 patients who at the first visit were considered to have Cough Variant Asthma (CVA), 47.14% resulted to have 
GERD as a cofactor to cough and 42.86% resulted to have PNDS as a cofactor.The methacolline challenge test resulted to be 
positive in 89.13% of the patients at the first visit toward 62.85% who resulted positive at the third visit(p<0.05).The value of 
Exhaled nitric oxid was elevated at the first visit only in 51.28% of the patients toward 50% who had a high level of it at the third 
visit. 
Conclusion and discussion   
GERD remains still the most frequent cofactor of chronic productive cough as a variant of asthma. 
 
Introduction 
Methacholine challenge test is important in evaluating a patient with dry chronic cough associated with 
bronchial hyperreactivity wheareas exhaled nitric oxid remains the most important non invasive test in the 
following the evolution of an airway inflammation. 
The management of chronic cough presentes a challenge for the clinician. Typically defined as a cough 
that persists for longer than 8 weeks , this is the most common presenting symptom in adults who seek medical 
treatment in an ambulatory setting. 
1. Chronic cough is estimated to occur in up to 40% of the population. 
2. Indeed, inflamatory mediators in the lower airways are elevated in patients with postnasal drip 
syndrome, cough variant asthma and GERD.Since the etiology of chronic cough can arise from anywhere in the 
tracheobronchial tree,, a multidisciplinary approach is often needed. 
3. Synonyms of methacholine challenge test is mecholyl challenge, bronchial provocation test.  
Indications of this test  
Diagnose asthma,confirm diagnosis of asthma,document severity of hyperresponsiveness and follow 
changes in hyperresponsiveness. 
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Contraindications 
Absolute contraindication include FEV1less than 1.5l in adults,less than 1l in children, recent severe 
acute asthma, myocardial infarction or cerebral vascular accident within 3 months and arterial aneurism. 
Relative contraindication include moderate baseline airway obstruction, spirometry-induced 
bronchoconstriction,URI,exacerbation of asthma,HTA, pregnancy, epilepsi. 
The reporting of the PC20 (Provocative concentration in mg/ml causing a 20% fall in FEV1 from 
baseline) is the usual method of expressing the results of a positive test. 
Measurement of exhaled nitric oxide offers an easy, noninvasive alternative to direct sampling of the 
lower airways by sputum induction, lavage,or biopsy. The fractional concentration of exhaled nitric oxide (FE 
NO) in asthma may have the utility of helping make diagnosis, monitoring the patients compliance with 
prescribed medications and predicting pending exacerbations.clinical instruments for the measurement of 
exhaled NO typically measure ‗online‘ (patient exhales directly into the measuring device) rather than ‗offline‘ 
(exhaled breath is collected into a sample bag for later measurement) Offline measurements may have utility in 
epidemiology and research. 
Background  
For many years it has been talking about the chronic non productive cough as the main manifestation of 
Asthma, Post – Nasal Drip Syndrome (PNDS), and Gastro – Esophageal Reflux Disease (GERD). The aim of 
our study was the follow up of a patient presented only with dry chronic cough:Which is the main diagnostic 
procedure and the most effective therapeutic approach available for such patients at the first medical visit and 
during his follow up? 
Methods  
Seventy patients (21 males and 49 females) age of 40, 47 year,presented only with chronic non 
productive cough were studied.The exclusion criteria were: non – smoking for at least 1 year , not having 
diseases of immune system, not receiving any angiotensin converting enzyme. They did accomplish 3 medical 
controls for a period of 8 months with a distance of 4 months from each other.Atopic status was evaluated by 
measuring total IgE, specific IgE, Eosinofilic Cationic Protein (ECP) and Eosinofilic Protein X (EPX). A 
detailed history was taken to evaluate the existence of other contributing factors to chronic cough such as: 
Athma, GERD, PNDS, and any respiratory infections. All the patients underwent the lung function tests. Only 
65.71% of them accepted to undergo the Methacholline challenge test and the measurement of Exhaled nitric 
oxid, at the first second and at the third control. According to the medical history and to the examination 
results,specific therapeutic schemes were used. 
Results  
From 41 patients who at the first visit were considered to have Cough Variant Asthma (CVA), 47.14% 
resulted to have GERD as a cofactor to cough and 42.86% resulted to have PNDS as a cofactor. Measurment of 
specific IgE resulted to be the most indicative method for the evaluation of atopic status.The methacolline 
challenge test resulted to be positive in 89.13% of the patients at the first visit toward 62.85% who resulted 
positive at the third visit(p<0.05).The value of Exhaled nitric oxid was elevated at the first visit only in 51.28% 
of the patients toward 50% who had a high level of it at the third visit.This value did not change very much from 
the first to the third visit which was related to the persistence of the respiratory mucosal inflammation and the 
need for the continuation of the therapy. 
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The antileucotriens were the most indicated drugs after the first visit (in 48.57% of the patients)which 
persisted in 37.14% after the third visit.The use of associations (Long acting B2Agonist (LABA)+Inhaled 
Corticoids (IC), together with antileucotriens , was the most effective therapeutic scheme indicated after the first 
visit.There was a significant reduction (p<0.05) in the need for the use of LABA,from 18.57% in the first visit to 
2.865 sfter the third one. 
Conclusion and discussion  
GERD remains still the most frequent cofactor of chronic productive cough as a variant of asthma. 
Methacholine challenge test is important in evaluating a patient with dry chronic cough associated with 
bronchial hyperreactivity wheareas exhaled nitric oxid remains the most important non invasive test in the 
following the evolution of an airway inflammation. 
The long term use of antileucotriens may be a good opportunity for a better long – term of the chronic 
non productive cough as a variant of asthma.  
Methacholine is used for identifying bronchial hyperresponsiveness and to guide treatment.(9,10) 
In clinical practice, assessment of FeNO concentration can be used as a screening test for asthma in 
young adults who have chronic cough.(12) 
The measurement of FENO is evolving to provide a complementary role alongside existing pulmonary 
function tests. Further work is required to establish reference values and possibly prediction equations in relation 
to age and height. Its role in determining optimum steroid requirements in chronic asthma and to identify steroid 
responsiveness in chronic obstructive pulmonary disease are two important areas for future research.(8) 
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